Immune checkpoint inhibitor lung injury is not uncommon and needs to be recognized

Immune Checkpoint Inhibitor - Nivolumab - Lung Injury / ILD and Recognizing Pre-Existing ILA/ILD

Immune checkpoint inhibitor lung injury is not uncommon and needs to be recognized

Bhavin Jankharia

This 73-years old man presented with nivolumab induced lung injury with an organizing pneumonia (OP) pattern. He also had pre-existing interstitial lung abnormality (ILA).

The video discusses the case, the follow-up, immune checkpoint inhibitor (ICI) related lung injury, which is a growing problem and the importance of pre-existing ILA

Free to view till 27 Jun

This post is for subscribers only

Subscribe Now

Already have an account? Log in